Acutus Medical, Inc. (NASDAQ:AFIB) Short Interest Update

Acutus Medical, Inc. (NASDAQ:AFIB) saw a large decrease in short interest during the month of April. As of April 15th, there was short interest totalling 553,600 shares, a decrease of 34.5% from the March 31st total of 845,200 shares. Based on an average trading volume of 2,250,000 shares, the short-interest ratio is presently 0.2 days. Currently, 2.9% of the company’s stock are sold short.

Acutus Medical Stock Performance

Shares of Acutus Medical stock opened at $0.16 on Friday. The company has a current ratio of 2.44, a quick ratio of 2.22 and a debt-to-equity ratio of 1.10. The stock has a fifty day simple moving average of $0.19 and a 200 day simple moving average of $0.26. Acutus Medical has a 12-month low of $0.16 and a 12-month high of $1.09. The company has a market capitalization of $4.86 million, a P/E ratio of -0.13 and a beta of 0.19.

About Acutus Medical

Acutus Medical, Inc, an arrhythmia management company, designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs.